Search results
Showing 1726 to 1740 of 2581 results for methods
In development Reference number: GID-TA11443 Expected publication date: TBC
In development Reference number: GID-TA11455 Expected publication date: TBC
In development Reference number: GID-TA10780 Expected publication date: TBC
Discontinued Reference number: GID-MT163
Bempegaldesleukin with nivolumab for untreated unresectable or metastatic melanoma
Discontinued Reference number: GID-TA10970
Masitinib for previously treated moderate Crohn's disease [ID1239]
Discontinued Reference number: GID-TA11188
Discontinued Reference number: GID-TA11206
Discontinued Reference number: GID-TA11207
Ovarian (epithelial), fallopian, peritoneal cancer - paclitaxel (encapsulated in XR-17 [ID565]
Discontinued Reference number: GID-TA11209
Multiple myeloma (untreated) - carfilzomib (with melphalan and prednisone) [ID1133]
Discontinued Reference number: GID-TA11210
Discontinued Reference number: GID-MT81
In development Reference number: GID-TA11689 Expected publication date: TBC
In development Reference number: GID-TA10589 Expected publication date: TBC
In development Reference number: GID-TA11546 Expected publication date: TBC
Discontinued Reference number: GID-TA10910